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Abstract
Background: Each year an estimated four million neonates die, the majority in the first week of life. One of the
major causes of death is sepsis. Proving the incidence and aetiology of neonatal sepsis is difficult, particularly in
resource poor settings where the majority of the deaths occur.
Methods: We conducted a three year observational study of clinically diagnosed early onset (<7 days of age)
neonatal sepsis (EONS) in infants born to mothers following antenatal care at the Shoklo Malaria Research Unit
clinic in Maela camp for displaced persons on the Thailand-Myanmar border. Episodes of EONS were identified
using a clinical case definition. Conventional and molecular microbiological techniques were employed in order
to determine underlying aetiology.
Results: From April 2009 until April 2012, 187 infants had clinical signs of EONS, giving an incidence rate of 44.8
per 1000 live births (95% CI 38.7-51.5). One blood culture was positive for Escherichia coli, E. coli was detected in
the cerebrospinal fluid specimen in this infant, and in an additional two infants, by PCR. Therefore, the incidence of
bacteriologically proven EONS was 0.7 per 1000 live births (95% CI 0.1 – 2.1). No infants enrolled in study died as a
direct result of EONS.
Conclusion: A low incidence of bacteriologically proven EONS was seen in this study, despite a high incidence of
clinically diagnosed EONS. The use of molecular diagnostics and nonspecific markers of infection need to be
studied in resource poor settings to improve the diagnosis of EONS and rationalise antibiotic use.
Background
Infections are the commonest cause of death in infants
less than four weeks old (neonates) [1-3]. Every year an
estimated four million neonates die; 99% of these deaths
occur in the developing world with the majority in the
first week of life [4-6].
Neonatal sepsis can be defined clinically and/or by
positive microbiology from normally sterile site specimens
(blood, cerebrospinal fluid (CSF) or urine obtained in
a sterile manner). A diagnosis of neonatal sepsis based
only on microbiological findings will under estimate the
true burden of neonatal sepsis [7]. However, information
regarding pathogen-specific disease incidence can only
be derived from studies that rely on microbiological
diagnosis. Unfortunately there are various reasons why
microbiological confirmation may not be possible, par-
ticularly in the developing world. These include limited
laboratory facilities, difficulty in obtaining a sufficient
quantity of blood from a small infant and suppression
of bacterial growth in cultures by antibiotics given in
labour [8].
A recent review of the pathogens associated with
infection in infants in the developing world reported
that in infants less than seven days (early onset neonatal
sepsis (EONS)) Gram negative organisms predominated,
in a ratio of 2:1, with Escherichia coli being the most
commonly isolated pathogen. The authors suggested that
the reason that Gram negative organisms predominated in
EONS is that they were environmentally acquired during
unhygienic birth practices [9].
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Historically, infection with GBS has been reported to be
extremely rare in the developing world [1]. Explanations
for this include less maternal carriage or less virulent
strains of GBS, but also study design [10]. EONS GBS
disease presents early in life with 90% of cases of sepsis
presenting within 12 hours of birth [11,12]. Therefore,
studies looking at EONS in community born infants
presenting to hospitals will be biased, as infants with
EONS GBS have a high likelihood of dying at home or on
the way to the hospital. Additionally, a recent systematic
review demonstrated that studies in which the use of
intrapartum antibiotics (IAP) are reported are associated
with lower rates of EO GBS disease [13]. More recent
African studies have reported much higher rates of early
onset neonatal GBS infection [14-18]. A review paper
by Seale et al. concludes that these higher recorded
incidences are due to more sensitive study designs that
focus on infants born in hospital, who develop early
onset sepsis, and not on outpatient referrals [19].
Mortality from neonatal sepsis, from any cause, is
high, even when treated. Case fatality rates of 5 – 60%
are reported with the highest mortality rates occurring
in developing countries [6,20]. A large multicentre case
controlled study performed in the USA between 1995
and 1996 showed an incidence of EONS of 3.5 per 1000
live births with 16% of these neonates dying [21].
The aims of the current study were to: (i) describe the
epidemiology of clinically diagnosed EONS in a rural South
East Asian refugee population and (ii) to attempt to
determine the aetiology of EONS, in particular to ascertain
whether GBS is an important pathogen in the area.
Methods
Study population
Maela is a crowded camp for displaced persons from
Myanmar located on the north-western border of Thailand.
Approximately 50,000 refugees live in a 4 km2 area and
most refugees are from the Karen ethnic group. Shoklo
Malaria Research Unit (SMRU) has been providing onsite
medical and obstetric care in Maela since 1986. There
are approximately 1,500 deliveries per annum in the
camp and 90% of pregnant women attend SMRU’s
antenatal clinics, with 80% of these women delivering
at the SMRU obstetric unit. Deliveries are performed
by skilled birth attendants. Complex obstetric cases and
women requiring a caesarean section for delivery are
transferred to the local Thai Hospital in Mae Sot
(60 km away). Gestation of all infants born to mothers
following antenatal care is routinely estimated either at
the first antenatal consultation by USS or by Dubowitz
gestational assessment after delivery [22,23]. Using popu-
lation norms, an infant is determined to be small for
gestational age (SGA) if their weight falls below the 10th
centile for weight [24]. All neonatal care is undertaken in
the Special Care Baby Unit (SBCU), located in the SMRU
clinic. The pregnant population has a low rate of HIV and
syphilis [25].
Enrolment criteria
Over a three year period the mothers of all infants clin-
ically diagnosed with EONS and admitted to the SCBU
in Maela camp were asked to participate in the study.
Informed written consent was obtained in a timely manner
so as not to delay treatment of the infants. In order to
determine the accurate mortality from EONS and to
maximise the possibility of obtaining a positive blood
culture, infants were excluded from being enrolled into
the study if they had a severe congenital abnormality
identified prenatally or at birth, or had received antibi-
otics within the early neonatal period (≤6 days of age).
We diagnosed EONS clinically using previously pub-
lished criteria: an infant less than seven days of age with a
fever (>38°C on one occasion or >37.5°C on two occasions
separated by at least one hour) or at least two clinical
features (poor perfusion, respiratory distress, persisting
glucose imbalance, abdominal distension, bilious aspirates,
or blood in the stool in a baby <72 hours of age) [26].
EONS could not be diagnosed using biochemical or
haematological parameters, since the SMRU laboratory
is located 60 km away.
Specimen collection and laboratory testing
Once a diagnosis of EONS was made clinically and consent
obtained, the following samples were collected from the
infant: complete blood count (PocH-one 100i, Sysmex),
C-reactive protein (NycoCard, Axis-Shield), blood culture
and cerebrospinal fluid (CSF). A vaginal-rectal swab was
obtained from the mother.
Blood cultures
One millilitre of venous blood was collected into a BacT/
ALERT PF culture bottle (bioMerieux). From 2nd April
2011 until the end of the study all blood culture bottles
were weighed before and after blood collection to permit
calculation of the volume of blood collected. The bottle
was incubated at 37°C for up to five days in a BacT/
ALERT 3D 60 instrument before being discarded as
negative. Bottles with a positive growth signal were vented,
examined by Gram stain, and sub-cultured onto appropri-
ate agar plates (Clinical Diagnostics). Cultured organisms
were identified by conventional microbiological techniques.
Coagulase negative staphylococci, diphtheroids and Bacillus
species were considered contaminants [27].
CSF specimens
CSF specimens were examined on site and a cell count
performed. The remaining specimen was sent to the SMRU
microbiology laboratory for Gram stain and microbiological
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culture. Unfortunately protein estimation was unable
to be performed as this investigation was not available
in the SMRU laboratory. An aliquot of CSF was stored
at −80°C for pathogen-specific PCR. Briefly, DNA was
extracted from 200 μL of thawed CSF using an automated
extraction protocol (Genomic DNA Whole Blood kit,
MagCore HF16, RBC Bioscience). Multiplex PCR assays
were used to detect Chlamydia trachomatis, E. coli, GBS,
Listeria monocytogenes, Staphylococcus aureus, Ureaplasma
urealyticum, cytomegalovirus, adenovirus, enteroviruses
and parechoviruses following the manufacturer’s protocol
(FTD Neonatal sepsis kit, Fast-track Diagnostics).
Vaginal-rectal swabs
Vaginal-rectal swabs were collected and processed accord-
ing to the CDC guideline for detection of GBS colonisation
[28]. Briefly, swabs were cultured overnight in LIM broth
and 10 μL of this broth was sub-cultured onto 5% sheep
blood agar and incubated overnight in 5% CO2 at 36°C.
Morphologically suspected GBS colonies were confirmed
as described above. All GBS isolates were serotyped by latex
agglutination (Strep-B-Latex kit, Statens Serum Institute).
Those isolates that were non-typeable by this serotyping
method or had a weak positive reaction were further
characterised using multiplex PCR assays based on the
detection of GBS capsular genotypes (Ia, Ib-IX) [29]. In
addition to culture, an aliquot of LIM broth culture was
used for detection of GBS by PCR, as previously described
[30]. GBS capsular genotype was determined by for
those specimens with a positive GBS PCR, by the same
multiplex PCR assays used for cultured isolates.
Clinical management
After the specimens were obtained the infant was com-
menced on antimicrobial treatment: intravenous ampicil-
lin and gentamicin. A presumptive diagnosis of meningitis
was made if the CSF WBC was above the upper limit of
normal (30×109/L [31]), in these cases intravenous cefo-
taxime was also given. The length of antibiotic treatment
was determined on microbiological results. If the CSF was
culture negative but the WBC was >50×109/L, a diagnosis
of meningitis was made and cefotaxime was continued
for ≥10 days [27].
The infant was discharged from hospital when com-
pletely recovered and afebrile, was breast feeding well
and gaining weight. The infant was then followed up at
seven and 28 days of age to ensure that they were well
and thriving.
Data analysis
Data were entered into an Access 2003 database (Micro-
soft) and statistical analyses carried out using Stata/IC
12.1 (StataCorp). Student’s t-test was used to compare
means and the two-sample Wilcoxon rank sum test was
used to compare medians. The Chi-squared test was used
to compare proportions, with two-tailed p-values of <0.05
indicating significance.
Ethical approval
All women gave informed consent to participate in the
study. Ethical approval was granted by the Ethics Committee
of The Faculty of Tropical Medicine, Mahidol University,
Thailand (MUTM 2009-011-03) and the Oxford Tropical
Research Ethics Committee, Oxford University, UK (48–08).
Results
Between 20th April 2009 and 19th April 2012, 196 episodes
of EONS were diagnosed. One neonate, born at home, died
before he could be enrolled. Five further infants, who
fulfilled the clinical criteria for a diagnosis of EONS were
identified on subsequent clinical record review and seven
infants with clinical signs of EONS could not be enrolled
as they had already started on antibiotics (because of the
presence of risk factors for EONS but not clinical features
of sepsis). A total of 183 infants were recruited into the
study. Nine (5%) of these infants were recruited in error as
they did not meet the inclusion criteria. The remaining
174 infants are described further (Figure 1).
Incidence of early onset neonatal sepsis
There were 4,173 live births to women following ante-
natal care with SMRU over the study period, giving an
incidence for clinically diagnosed early onset neonatal
sepsis of 44.8 per 1,000 live births (187/4,173, 95% CI
38.7-51.5). There were peaks in the incidence of EONS
in March and April each year, the hottest months of the
year (Figure 2).
Figure 1 Summary of EONS cases from April 2009 until April
2012 in Maela Camp and enrolment into the study.
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Infant characteristics
Of the infants enrolled, 96/174 (55.2%) were male. The
median gestation was 39+5 weeks (range 30+5 to 41+6);
10/174 (5.8%) of infants were born prematurely (>28 to
36 +6 weeks). The median birth weight was 3.17 kg (range
1.42 – 5.08 kg), 12/172 (7.0%) were small for gestational
age. The majority of the infants enrolled were born at the
SMRU clinic, with few being born at home (5/174, 2.9%)
or in Mae Sot hospital (3/174, 1.7%).
Early onset neonatal sepsis episodes
The median age of admission to SCBU for clinically
diagnosed EONS was one day (range 0 – 5 days). The
commonest reason for enrolment into the study was a
fever >38°C (Table 1).
Only 5/174 (2.9%) infants had two or more clinical
features of EONS and one of these infants also had a
temperature >38°C. Of the infants with a temperature
of >38°C, 8/104 (7.7%) also had other clinical signs of
sepsis. Of the infants with a temperature >37.5°C on
two occasions, 14/66 (21.2%) also had other clinical signs
of sepsis. Therefore 147/174 (84.5%) of EONS cases were
diagnosed by fever alone.
Investigations
Blood cultures were positive in 40/171 cases and in 39
(22.8%) these were believed to be contaminants. Escherichia
coli was identified from one blood culture (1/171; 0.3%).
The mean volume of blood sent for blood culture was
0.8 ml (SD 0.5 ml).
A total of 135 lumbar punctures were successfully
performed (77.6% of all infants enrolled). Of these, 130
had a cell count performed and 13 (10.0%) had a WBC
count >50x109/L. There was a trend for a significantly
higher CRP in these infants as compared to those who
had a CSF WBC of <50x109/L (p = 0.06). There were no
clinically significant bacterial isolates cultured. One
hundred and thirty two CSF samples underwent patho-
gen-specific PCR. E. coli DNA was found in three samples
(one of which was from the infant in whom E. coli was
cultured from blood). All three infants were term and
of normal birth weight. All presented before 72 hours
of age with a fever and no other clinical signs of sepsis.
Two of the mothers had prolonged rupture of membranes
(> 18 hours, PROM) and were treated with antibiotics
during labour (one with ampicillin and one with amo-
xicillin), the third had no documented prior antibiotic
exposure. All three of the infants had a CRP taken, the
neonate with the positive blood culture had the highest
value (46 mg/L) and the other two had CRP values of 8
and 12 mg/L. None of these infants had a raised WBC
in their CSF, with the CSF white cell counts being 6, 4
and 2x109/L.
Figure 2 Number of EONS episodes per 1000 live births, by month of diagnosis (primary axis; solid line). Mean monthly temperature
(secondary axis; dashed line).
Table 1 Clinical features of 174 neonates diagnosed with
EONS and enrolled into the study




>37.5°C on two occasions separated
by at least one hour
66 (37.9)
Poor perfusion 5 (2.9)
Respiratory distress 15 (8.6)
Persisting glucose imbalance 3 (1.7)
Abdominal distension 2 (1.2)
Bilious aspirates 3 (1.7)
Blood in the stool in a baby < 72 hours of age 1 (0.6)
*some babies had more than one feature hence total number is great
than 174.
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Maternal vaginal rectal swabs
GBS was cultured from 4/170 (2.4%) maternal vaginal
swabs and a further 11 swabs were GBS positive by PCR,
giving an overall carriage rate of 8.8% (95% CI 5.0 – 14.2).
This prevalence is not significantly different to that
found in a GBS carriage study described previously in
this population (12.0%; p = 0.3) [30]. None of the mothers
who had a vaginal swab positive for GBS by culture
received antibiotics in labour while 2/11 (18.2%) of the
GBS positive by PCR had received antibiotics during
labour. Serotype III was the most common GBS serotype
identified by culture and serotype Ib was the most
common serotype detected by PCR.
Complete blood count
The median WBC value was 13.6 with a range of 5.4 –
38.0×106/L. No infants with EONS had a WBC of
<5.0×106/L but nine infants (5.3%) had a raised WBC
(>26.0×106/L [32]. Of the infants with EONS, 18/171
(10.5%) had a platelet count of <150 × 109/L. Of the
infants who were diagnosed on clinical signs alone (i.e.
no fever), 4/5 (80%) had a low platelet count (p < 0.0001).
C-reactive protein
C-reactive protein results ranged from the lowest limit
of detection (8 mg/L) to 109 mg/L; 86/165 (52.1%) had a
CRP >8 mg/L.
Maternal characteristics
The median age of the mothers was 26.5 years (range
16.0 – 44.0 years); 7/174 (4.0%) of the mothers were <18 years
old. The median gravidity of these women was two (range
1 – 10) and parity two (range 1 – 10). Fourteen (8.1%)
mothers had a previous neonatal death, ten of which
occurred in the early neonatal period. The causes of
death were generally unknown but three reported that
their infant was born prematurely and one that their
infant died of jaundice. Four of these infants died at
home without their parents seeking medical care.
Labour
The median length of rupture of membranes (ROM)
was 3.1 hours (range 0 minutes – 17 days). Twenty nine
(29/171, 17.0%) women had PROM (ROM >18 hours).
This was significantly higher than the proportion of
women who had PROM in a previously published study
on GBS carriage, in the same population (17.0% versus
7.3% p < 0.001 [30]). Overall 33/171 (19.3%) women
received antibiotics during labour. Of the women with
PROM, 28/29 (97%) received antibiotics in labour.
Twenty six (26/28, 93.0%) received ampicillin, 1/28 (3.6%)
received amoxicillin and 1/28 (3.6%) received ceftriaxone.
Four other women received antibiotics in labour: three
received ampicillin (two for chorioamnionitis and one for
pyelonephritis) and one ciprofloxacin (for pyelonephritis).
The median interval between antibiotic administration
and delivery was nine hours (range 0 – 36 hours). Nine
women had a documented fever during labour and four of
these women received antibiotics.
Outcomes
The median length of hospital admission was five days
but the range was large, from 2 – 46 days. There were
two (1.1%) early neonatal deaths in the study infants;
however neither death was directly related to the sepsis
episode. One infant had Down’s syndrome and a congeni-
tal cardiac malformation and one was born at 30 + 5 weeks
gestation and died of clinically diagnosed respiratory
distress syndrome.
Discussion
This three year observational study identified neonates
who had clinical features of EONS and were born to
mothers who had antenatal care in a refugee camp on the
Thailand-Myanmar border. The objective of the study
was to describe the epidemiology of clinically diagnosed
EONS and to investigate possible bacterial causes and
in particular GBS.
The incidence of EONS using a clinical definition was
44.8 episodes per 1,000 live births. It is not possible to
compare this figure to that of other studies as clinically
diagnosed EONS is not usually reported. This is unfortu-
nate as we recognise that the true burden of neonatal
sepsis will be greater than that which is simply based on
positive blood cultures.
The majority of infants were diagnosed with EONS
because they had a fever. Only four infants were diag-
nosed as having EONS because of the presence of other
clinical signs. All temperatures were taken rectally
and therefore accurately reflect core body temperature.
Although correctly taking a rectal temperature does
require training it is more straight forward to teach and
to ensure accuracy (as the outcome is objective and not
subjective) than the recognition of clinical signs. Hence
it may be reasonable to use only the presence of fever
as a diagnostic criterion for EONS in health care facil-
ities run by staff with limited training. The incidence of
EONS increased in March – May, corresponding to the
hot season. This begs the question as to whether the
infants who were diagnosed with EONS because of a
fever in this time period, had a fever because of the
high ambient temperature and not because they had
true EONS.
Using clinical features alone may overestimate the
incidence of EONS leading to the overuse of antibi-
otics. In our study only 86/165 (52.1%) infants who
were clinically diagnosed as having EONS had a raised
CRP at presentation. The National Institute for Health
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and Clinical Excellence has published guidelines for the use
of antibiotics for EONS [33]. These guidelines recommend
starting antibiotics in any neonate who has clinical signs of
sepsis but to repeat a CRP measurement 18 – 24 hours
after starting treatment, to determine those infants who
truly do have sepsis. Adopting this strategy would increase
the accuracy of calculating the incidence of neonatal sepsis
in an environment where microbiological diagnosis is
not possible.
The incidence of bacteriologically proven EONS was
0.7 per 1,000 live births (95% CI 0.1 – 2.1). This inci-
dence is lower than that reported from other developing
country settings. For example, in Kenya, Berkley et al.
report a minimal rate for neonatal bacteraemia of 5.5
per 1,000 live births [14]. It was also notable that a
significant proportion (10%) of infants who had an LP
performed were found to have a raised CSF white cell
count (>50 cells/mm3). Using a “normal” definition of < 20
white cells [34] increases this proportion to 30%, yet a
pathogen was not detected in any of these samples.
Escherichia coli was the only pathogen isolated from a
blood culture and the only pathogen identified in CSF.
The mothers of two of the three infants with a positive
CSF E. coli PCR had received antibiotics in labour,
potentially explaining the lack of bacterial growth. Specific
PCRs were not available for all potentially relevant bacteria
(e.g. Klebsiella spp.), thus we cannot exclude the possibil-
ity that other bacteria were implicated.
One explanation for the lack of positive microbiology
is the high quality antenatal care that women living in
Maela camp receive and the high rate of deliveries with
skilled birth attendants, resulting in prompt antibiotic
administration during labour when necessary. A signifi-
cant proportion of women whose babies subsequently had
clinical sepsis had prolonged rupture of membranes and
97% of these women had received antibiotics in labour.
One other significant factor is the use of un-prescribed
antibiotic use in the community. Antimicrobials are readily
available for purchase at many shops within Maela. A
survey conducted in 2011 found that 25% of pregnant
women had evidence of antimicrobial activity in their
urine suggesting recent antimicrobial consumption (un-
published data). Maternal antibiotic use could suppress
bacterial growth in samples collected from neonates,
decreasing the conventional microbiological utility in
determining aetiology.
It is conceivable that the use of specific PCRs against a
larger number of potential pathogens (e.g. Klebsiella spp.,
additional viruses, etc.) might increase the yield of the CSF
samples. Further work should be focused on this apparent
burden of infection.
A further possible explanation for the low bacteraemia
incidence is the amount of blood collected for each
blood culture sample and the high bacterial contamination
rate. However both values were similar to that reported by
Berkley et al. [14].
GBS is increasingly being reporting as a significant
pathogen in the developing world, particularly in Southern
Africa [15,18]. However GBS is unlikely to be an import-
ant pathogen in the current study described here. One
explanation is that the proportion of women found to
be colonised with GBS was relatively low. Additionally,
there was significant use of IAP in this population, with
nearly 20% of all women receiving IAP and 76.9% of
women with significant risk factors for EOGBS (PROM,
premature delivery and fever) receiving IAP. It is therefore
conceivable that these antibiotics suppressed the growth
of GBS in conventional cultures resulting in clinical
disease with negative cultures. This suggests a potential
role for molecular diagnostics and, although a GBS-
specific PCR was possible for CSF samples (yielding no
cases of GBS meningitis), it was not possible to do this
on blood samples. The burden of EOGBS may therefore
still be underestimated. It is also conceivable that the
use of IPA could delay the onset of sepsis, however in
the population described in this manuscript no neonate
developed late onset sepsis from 7 – 28 days of age).
The majority of infants enrolled into the study were
born at SMRU’s clinic. It has been argued that inborn
infants are often over represented in studies on EONS
as neonates who are born at home and develop EONS
may die before reaching a health care facility [19]. This
was not the case with our study, as all infants born to
mothers who followed ANC at SMRU Maela were
reviewed at 28 days of age in order to determine the
neonatal mortality rate of the population. No infant
was identified as having died from a potential septic
episode at home.
No infant who was enrolled in this study died as a
direct result of EONS. The only death from EONS that
occurred at SMRU during the study period was in
2009, before the infant could be enrolled into the study.
In total there were 55 early neonatal deaths over the
study period. Using Lawn’s estimation that 26% of neonatal
deaths are caused by sepsis, we could have expected to
see 14 neonatal deaths due to EONS in this population
in the time period studied. The explanation for this is
multifactorial. Women received antibiotics when present-
ing with PROM and this may have reduced the infant’s
risk of developing EONS. Additionally, medical staff were
trained in the recognition of EONS and management
protocols were clear.
Conclusion
In conclusion, we have presented a three year study
defining the epidemiology of EONS in a SE Asian refugee
population. E. coli was the only bacteria isolated and GBS
was not found to be the cause of any EONS episodes. The
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lack of bacterial isolates from conventional microbio-
logical culture, potentially due to high antibiotic use in
the community (both medically prescribed and self-
administered), highlights a problem common to many
resource poor settings. The use of nonspecific markers of
infection should be examined in these settings in order to
make more accurate diagnosis of sepsis in infants.
We postulate that rigorous use of locally appropriate
guidelines (including IAP), obstetric and neonatal, a high
proportion of deliveries with skilled birth attendants, regu-
lar training and motivated staff, resulted in the absence of
EONS-attributable mortality in infants born in Maela.
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